openPR Logo
Press release

Chemotherapy-Induced Nausea and Vomiting Drugs Market Status and Outlook (2022-2028)- Global SWOT Analysis, Latest Industry Trends, Growth & Scope by Top Key Players

06-30-2022 08:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ReportsnReports.com

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant

Segment by Application
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists

Get a Free Sample Copy @
https://www.reportsnreports.com/contacts/requestsample.aspx?name=5899306

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

By Company
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.

Get a 20% Discount on Direct Purchase @
https://www.reportsnreports.com/contacts/discount.aspx?name=5899306

Table of Contents

1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2028
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028
1.4.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue
2.5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2017-2022

Inquire Before Buying @
https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=5899306

3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.4.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.

Buy This Research Report @
https://www.reportsnreports.com/purchase.aspx?name=5899306

Phone: +1 888 391 5441
Email: sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
We provide 24/7 online and offline support to our customers

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemotherapy-Induced Nausea and Vomiting Drugs Market Status and Outlook (2022-2028)- Global SWOT Analysis, Latest Industry Trends, Growth & Scope by Top Key Players here

News-ID: 2668366 • Views:

More Releases from ReportsnReports.com

Remote Patient Monitoring Software Market Size in 2023 To 2029 | eVisit, CarePat …
The Remote Patient Monitoring Software research report provides detailed measurements and analysis of the drivers, development, and prospects that directly influence the market. It offers an in-depth analysis of the international Remote Patient Monitoring Software Market, considering key factors such as drivers, sales inquiry, market limits, and market share. By examining these key boundaries and regions, the report provides valuable information for organizations looking to enter or expand their presence
Global Biobased Polylactic Acid (PLA) Market Size, Industry Trends, Share, Opportunities, Drivers, Restraints and Forecast 2023-2029
Global Biobased Polylactic Acid (PLA) Market Size, Industry Trends, Share, Oppor …
Bio-based polylactic acid is a biodegradable polymer material, which is made from biomass materials such as sugar, starch and cellulose as raw materials, which are fermented to make lactic acid, and then polymerized from lactic acid to make polylactic acid polymer material. Don't Miss Out! Get 25% Off on Your Purchase of this Market Research Report! https://www.reportsnreports.com/contacts/discount.aspx?name=6708436 The global Biobased Polylactic Acid (PLA) market was valued at US$ million in 2022 and is
Exploring the Most Recent Trends and Insights in the Global Sales Project Management Tools Market: A Complete Research Report with Industry Size, Share, Growth & Scope 2023-2029
Exploring the Most Recent Trends and Insights in the Global Sales Project Manage …
Highlights The global Sales Project Management Tools market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Sales Project Management Tools is estimated to increase from $ million in 2023 to reach $ million by 2029, at
Global Sales Prospecting and Lead Generation Software Market 2023-2029: Industry Size, Share, Growth Prospects, Sector Dynamics, and Latest Technology Influence on the Consumer
Global Sales Prospecting and Lead Generation Software Market 2023-2029: Industry …
Highlights The global Sales Prospecting and Lead Generation Software market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Don't Miss Out! Get 25% Off on Your Purchase of this Market Research Report! https://www.reportsnreports.com/contacts/discount.aspx?name=6708434 North American market for Sales Prospecting and Lead Generation

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.